분당서울대학교병원에 찾아오시는 길입니다.
우)13620, 경기도 성남시 분당구 구미로173번길 82
분당서울대학교병원의 공지사항을 알려드립니다.
다양하고 유익한 건강상식을 제공해 드립니다.
진료시간표
요일 | 월 | 화 | 수 | 목 | 금 | 토 |
---|---|---|---|---|---|---|
오전 | ||||||
오후 |
[대표논문]
Ahmad E*, Lim S* (co-first author), Lamptey R, Webb DR, Davies MJ. Type 2 diabetes. Lancet 2022 Nov 19;400(10365):1803-1820. (SCI factor = 168.9).
Kadowaki T, Isendahl J, Khalid U, Lee SY, Nishida T, Ogawa W, Tobe K, Yamauchi T, Lim S (corresponding author). Effect of once-weekly subcutaneous semaglutide in adults with overweight or obesity, with or without type 2 diabetes, in an East Asian population. Lancet Diabetes Endocrinol 2022 Mar;10(3):193-206. (SCI factor = 44.5).
Lim S, Bae JH, Kwon HS, Nauck MA. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nature Rev Endocrinol. 2021 Jan;17(1):11-30 (SCI factor = 40.5).
Jang HJ, Kim YJ, Lee DH, Joo SK, Koo BK, Lim S, Lee WJ, Kim W. Differential Class Effects of Oral Anti-diabetic Drugs on Nonalcoholic Fatty Liver Disease. JAMA Intern Med. 2024 Feb 12:e238029. PMID: 38345802. (SCI factor = 39).
Lim S, Kim JW, Targher G. Links between Metabolic Syndrome and Metabolic Dysfunction-Associated Fatty Liver Disease. Trends Endocrinol Metab. 2021 Jul;32(7):500-514. (SCI factor = 10.9)
Moon JS, Hong JH, Jung YJ, Ferrannini E, Nauck MA, Lim S (corresponding author). SGLT-2 inhibitors and GLP-1 receptor agonists in metabolic dysfunction-associated fatty liver disease. Trends Endocrinol Metab. 2022 Jun;33(6):424-442. (SCI factor = 10.9).
Lim S, Kim KM, Nauck MA. Glucagon-like Peptide-1 Receptor Agonists and Cardiovascular Events: Class Effects versus Individual Patterns. Trends Endocrinol Metab. 2018 Apr;29(4):238-248. PMID: 29463450. (SCI factor = 10.9).
Ohn JH, Kwak SH, Cho YM, Lim S, Jang HC, Park KS, Cho NH. 10 Year Trajectory of β-cell Function and Insulin Sensitivity in the Development of Diabetes: Result of the Korean Genome and Epidemiology Study. Lancet Diabetes Endocrinol. 2016 Jan;4(1):27-34. (SCI factor = 44.5).
[2024]
Choe HJ, Chang W, Blüher M, Heymsfield SB, Lim S. Independent association of thigh muscle fat density with vascular events in Korean adults. Cardiovasc Diabetol. 2024 Jan 28;23(1):44. PMID: 38281946
Park YH, Sohn M, Lee SY, Lim S. Two-Year Therapeutic Efficacy and Safety of Initial Triple Combination of Metformin, Sitagliptin, and Empagliflozin in Drug-Naïve Type 2 Diabetes Mellitus Patients. Diabetes Metab J. 2024 Mar;48(2):253-264. PMID: 38273791
Choe HJ, Oh HR, Bu D, An N, Scherer PE, An Z, Lim S. Evaluation of the efficacy of a combination of dapagliflozin and lobeglitazone on glucose concentrations and body fat in patients with type 2 diabetes: Location-F study. Diabetes Obes Metab. 2024 Mar;26(3):1114-1119. PMID: 38073421
Sohn M, Lim S. The Role of Cilostazol, a Phosphodiesterase-3 Inhibitor, in the Development of Atherosclerosis and Vascular Biology: A Review with Meta-Analysis. Int J Mol Sci. 2024 Feb 23;25(5):2593. PMID: 38473840
Bae JH, Lim H, Lim S. Corrigendum to The Potential Cardiometabolic Effects of Long-Chain ω-3 Polyunsaturated Fatty Acids: Recent Updates and Controversies [Adv Nutr 14(4) (2023) 612-628]. Adv Nutr. 2024 Jan;15(1):100134. PMID: 38436217
Lim S, Lee SH, Min KW, Lee CB, Kim SY, Yoo HJ, Kim NH, Kim JH, Oh S, Won JC, Kwon HS, Kim MK, Park JH, Jeong IK, Kim S. A Multicenter, double-blind, placebo-controlled, randomized, parallel comparison, phase 3 trial to evaluate the efficacy and safety of pioglitazone add-on therapy in type 2 diabetic patients treated with metformin and dapagliflozin. Diabetes Obes Metab. 2024 Jun;26(6):2188-2198. PMID: 38425186
Son JW, Lim S. Glucagon-Like Peptide-1 Based Therapies: A New Horizon in Obesity Management. Endocrinol Metab (Seoul). 2024 Apr 16. doi: 10.3803/EnM.2024.1940. Online ahead of print. PMID: 38626909
Moon JH, Choe HJ, Lim S. Pancreatic beta-cell mass and function and therapeutic implications of using antidiabetic medications in type 2 diabetes. J Diabetes Investig. 2024 Jun;15(6):669-683. PMID: 38676410
Lim S, Sohn M, Michael A. Nauck MA. Cardiovascular outcome with SGLT2i and GLP1RA. Eur J Intern Med. 2024 Jun 6:S0953-6205(24)00235-8. doi: 10.1016/j.ejim.2024.05.030. Online ahead of print. PMID: 38849275
Sohn M, Nam S, Nauck MA, Lim S. Long-term comparison of renal and metabolic outcomes after sodium–glucose co-transporter 2 inhibitor or glucagon-like peptide-1 receptor agonist therapy in type 2 diabetes. BMC Med. 2024 Jul 2;22(1):273. doi: 10.1186/s12916-024-03483-z. PMID: 38956548
[2023]
Lim S, Sohn M. How to cope with emerging viral diseases: lessons from South Korea`s strategy for COVID-19, and collateral damage to cardiometabolic health. Lancet Reg Health West Pac. 2023 Jan;30:100581. PMID: 36093123
Sohn M, Jung H, Lee WS, Kim TH, Lim S. Effect of Lactobacillus plantarum LMT1-48 on Body Fat in Overweight Subjects: A Randomized, Double-Blind, Placebo-Controlled Trial. Diabetes Metab J. 2023 Jan;47(1):92-103. PMID: 35487505
Lim S, Sohn M, Florez JC, Nauck MA, Ahn J. Effects of Initial Combinations of Gemigliptin Plus Metformin Compared with Glimepiride Plus Metformin on Gut Microbiota and Glucose Regulation in Obese Patients with Type 2 Diabetes: The INTESTINE Study. Nutrients. 2023 Jan 3;15(1):248. PMID: 36615904
Kim K, Moon JH, Ahn CH, Lim S. Effect of olmesartan and amlodipine on serum angiotensin-(1-7) levels and kidney and vascular function in patients with type 2 diabetes and hypertension. Diabetol Metab Syndr. 2023 Mar 11;15(1):43. PMID: 36899369
Park D, Shin MJ, Després JP, Eckel RH, Tuomilehto J, Lim S. Twenty-Year Trends in Metabolic Syndrome Among Korean Adults From 2001 to 2020. JACC Asia. 2023 Jun 20;3(3):491-502. PMID: 37396427
Sohn M, Dietrich JW, Nauck MA, Lim S. Clinical Characteristics Predicting the Efficacy of SGLT-2 Inhibitors Versus GLP-1 Receptor Agonists on Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus: A Meta-analysis Study. Cardiovasc Diabetol. 2023 Jun 28;22(1):153. PMID: 37381019
Bae JH, Lim HJ, Lim S. The potential cardiometabolic benefits of long-chain omega-3 polyunsaturated fatty acids: a comprehensive review focusing on recent updates and controversies. Adv Nutr. 2023 Jul;14(4):612-628. PMID: 37031750
Kang SM, Yun HM, Sohn M, Lim S. Vascular and Metabolic Effects of Ipragliflozin Versus Sitagliptin in Type 2 Diabetes Treated with Sulfonylurea and Metformin: IVS study. Diabetes Obes Metab 2023 Jul;25(7):1922-1931. PMID: 36932823
Chung SM, Moon JS, Hong JH, Hwang IC, Lim S. Comparison of the effects of gemigliptin versus glimepiride on cardiac function in patients with type 2 diabetes uncontrolled with metformin: The gemi-heart study. Diabetes Obes Metab. 2023 Aug;25(8):2181-2190. PMID: 37046365
Hong JH, Moon JS, Seong K, Lim S. Comparison of therapeutic efficacy and safety of sitagliptin, dapagliflozin, or lobeglitazone adjunct therapy in patients with type 2 diabetes mellitus inadequately controlled on sulfonylurea and metformin: Third agent study. Diabetes Res Clin Pract. 2023 Sep:203:110872. PMID: 37574137
Lee JS, Sohn MJ, Kim KH, Yoon YS, Lim S. Glucose Regulation After Partial Pancreatectomy: A Comparison of Pancreaticoduodenectomy and Distal Pancreatectomy in the Short and Long Term. Diabetes Metab J. 2023 Sep;47(5):703-714. PMID: 37349082
Sohn M, Frias JP, Lim S. Cardiovascular efficacy and safety of antidiabetic agents: a network meta-analysis of randomized controlled trials. Diabetes Obes Metab. 2023 Dec;25(12):3560-3577. PMID: 37649320
[2022]
Sohn M, Na GY, Chu J, Joung H, Kim BK, Lim S. Efficacy and Safety of Lactobacillus plantarum K50 on Body Fat and Lipids in Koreans. Front. Endocrinol (Lausanne). 2022 Jan 19:12:790046. PMID: 35126309
Bae JH, Choe HJ, Holick MF, Lim S. Association of vitamin D status with COVID-19 and its severity: Vitamin D and COVID-19: a narrative review. Rev Endocr Metab Disord. 2022 Jun;23(3):579-599. (SCI factor = 9.306) PMID: 34982377
Lim S, Sohn M, Shin Y, Ferrannini E. Initial combination of metformin, sitagliptin, and empagliflozin in drug-naïve patients with type 2 diabetes: Safety and metabolic effects. Diabetes Obes Metab. 2022. Apr;24(4):757-762. PMID: 34908220
Del Orbe DV, Park HJ, Kwack MJ, Lee HK, Kim DY, Lim JG, Park I, Sohn M, Lim S (corresponding author)*, Lee DS,* Breath analyzer for personalized monitoring of exercise-induced metabolic fat burning. Sensors & Actuators: B. Chemical 369 (2022) 132192 (SCI factor = 9.221)
Sohn M, Chun EJ, Lim S. Cilostazol treatment for preventing adverse cardiovascular events in patients with type 2 diabetes and coronary atherosclerosis: long-term follow-up of the ESCAPE study. J Diabetes Aug;14(8):524-531. PMID: 35932165
Ko HJ, Kim JW, Lim S. Adherence to and dropout from liraglutide 3.0 mg obesity treatment in a real-world setting. J Obes Metab Syndr. 2022 Sep 30;31(3):254-262. PMID: 36050277
Lim S. Association between obesity and COVID-19. J Korean Med Assoc 2022 July; 65(7):423-429.
Yoon JW, Sohn M, Moon JH, Lim S. Accuracy of Y-scope, a newly developed portable abdominal impedance analyzer, for the assessment of abdominal visceral fat area. Frontiers in Nutrition Oct 12;9:950747. PMID: 36313090
Moon JS, Hong JH, Jung YJ, Ferrannini E, Nauck MA, Lim S. SGLT-2 inhibitors and GLP-1 receptor agonists in metabolic dysfunction-associated fatty liver disease. Trends Endocrinol Metab. 2022 Jun;33(6):424-442. (SCI factor = 10.586). PMID: 35491295
Kadowaki T, Isendahl J, Khalid U, Lee SY, Nishida T, Ogawa W, Tobe K, Yamauchi T, Lim S (corresponding author). Effect of once-weekly subcutaneous semaglutide in adults with overweight or obesity, with or without type 2 diabetes, in an East Asian population. Lancet Diabetes Endocrinol 2022 Mar;10(3):193-206. (SCI factor = 44.867). PMID: 35131037
Ahmad E*, Lim S* (co-first author), Lamptey R, Webb DR, Davies MJ. Type 2 diabetes. Lancet 2022 Nov 19;400(10365):1803-1820. (SCI factor = 202.731). PMID: 36332637
[2021]
Lim S, Bae JH, Kwon HS, Nauck MA. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nature Rev Endocrinol. 2021 Jan;17(1):11-30 (SCI factor = 43.33). PMID: 33188364
Kim JH, Lee GY, Maeng HJ, Kim H, Jae Hyun Bae JH, Kim KM, Lim S. Effects of glucagon-like peptide-1 analogue and fibroblast growth factor-21 combination on the atherosclerosis-related process in a type 2 diabetes mouse model. Endocrinol Metab (Seoul). 2021 Feb;36(1):157-170. PMID: 33677937
Lim S, Bae JH, Kwon HS, Nauck MA. Reply to: Autonomic dyshomeostasis in patients with diabetes mellitus during COVID-19. Nature Rev Endocrinol. 2021 Mar;17(3):189-190. PMID: 33462400
Park JH, Kim JY, Choi JH, Park HS, Shin HY, Lee JM, Kim JW, Ko HJ, Chon S, Kim BK, Kim CS, Lim S. Effectiveness of liraglutide 3 mg for the treatment of obesity in a real-world setting without intensive lifestyle intervention. Int J Obes (Lond). 2021 Apr;45(4):776-786. PMID: 33473176
Sohn M, Lee JE, Ahn M, YongKeun Park YK, Lim S. Correlation of dynamic membrane fluctuations in red blood cells with diabetes mellitus and cardiovascular risks. Scientific Reports Mar 26;11(1):7007. PMID: 33772071
Lim S, Kim JW, Targher G. Links between Metabolic Syndrome and Metabolic Dysfunction-Associated Fatty Liver Disease. Trends Endocrinol Metab. 2021 Jul;32(7):500-514. PMID: 33975804
Shin Y, Choi H, Lim S. Comparison between dapagliflozin add-on therapy and insulin dose escalation in patients with uncontrolled type 2 diabetes treated with insulin. Diabetes Res Clin Pract. 2021 May;175:108843. PMID: 33933498
Euh W, Lim S (cofirst author), Kim JW. Sodium-Glucose Cotransporter-2 Inhibitors Ameliorate Liver Enzyme Abnormalities in Korean Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease. Front. Endocrinol. 2021 Jun 10;12:613389. PMID: 34177796
Sohn M, Koo BK. Yoon HI, Song KH, Kim ES, Kim HB, Lim S. Impact of COVID-19 and Associated Preventive Measures on Cardiometabolic Risk Factors in South Korea. J Obes Metab Syndr. 2021 Sep 30;30(3):248-260. PMID: 34334371
Lim S, Kong AP, Tuomilehto J. Influence of COVID-19 pandemic and related quarantine procedures on metabolic risk. Prim Care Diabetes. 2021 Oct;15(5):745-750. PMID: 34312109
Lim S, Kim YJ, Khang A, Eckel RH. Postprandial dyslipidemia after a standardized high-fat meal in BMI-matched healthy individuals, and in subjects with prediabetes or Type 2 diabetes. Clinical Nutrition. 2021 Nov;40(11):5538-5546. PMID: 34656950
[2020]
Lim S, Oh TJ, Dawson J, Sattar N. Diabetes drugs and stroke risk: Intensive versus conventional glucose-lowering strategies, and implications of recent cardiovascular outcome trials. Diabetes Obes Metab. 2020 Jan;22(1):6-15. PMID: 31379119
Lim S, Ku EJ, Lee SY, Lee JH, Lee JE, Kim KM, Davies MJ. Therapeutic efficacy and safety of initial triple combination of metformin, sitagliptin, and lobeglitazone in drug-naïve patients with type 2 diabetes: initial triple study. BMJ Open Diabetes Res Care. 2020 Jan;8(1). PMID: 31958303
Kim G, Lim S (cofirst author), Kwon HS, Park IB, Ahn KJ, Park CY, Kwon SK, Kim HS, Park SW, Kim SG, Moon MK, Kim ES, Chung CH, Park KS, Kim M, Chung DJ, Lee CB, Kim TH, Lee MK. Efficacy and safety of evogliptin treatment in patients with type 2 diabetes: A multicentre, active-controlled, randomized, double-blind study with open-label extension (the EVERGREEN study). Diabetes Obes Metab. 2020 Sep;22(9):1527-1536. PMID: 32319168
Lim S, Lim H, Després JP. Collateral Damage of the COVID-19 Pandemic on Nutritional Quality and Physical Activity: Perspective from South Korea. Obesity (Silver Spring). 2020 Oct;28(10):1788-1790. PMID: 32543113
Lim S, Yoon HI, Song KH, Kim ES, Kim HB. Face masks and containment of COVID-19: experience from South Korea. J Hosp Infect. 2020 Sep;106(1):206-207. PMID: 32540463
Lim S, Moon JH, Shin CM, Jeong D, Kim B. Effect of Lactobacillus sakei, a Probiotic Derived from Kimchi, on Body Fat in Koreans with Obesity: A Randomized Controlled Study. Endocrinol Metab (Seoul). 2020 Jun;35(2):425-434. PMID: 32615727
Shin Y, Moon JH, Chin HJ, Ferrannini E, Lim S. Glycemic Efficacy and Metabolic Consequences of an Empagliflozin Add-on versus Conventional Dose-Increasing Strategy in Patients with Type 2 Diabetes Inadequately Controlled by Metformin and Sulfonylurea. Endocrinol Metab (Seoul). 2020 Jun;35(2):329-338. PMID: 32615717
Kim YJ, Hwang SD, Lim S. Effects of Sodium-Glucose Cotransporter Inhibitor/Glucagon-Like Peptide-1 Receptor Agonist Add-On to Insulin Therapy on Glucose Homeostasis and Body Weight in Patients with Type 1 Diabetes: A Network Meta-Analysis. Front Endocrinol (Lausanne). 2020 Aug 19;11:553. PMID: 32973680
Lee DH, Chun EJ, Moon JH, Yun HM, Lim S. Effect of cilostazol on carotid plaque volume measured by 3D ultrasound in patients with type 2 diabetes: FANCY study. Diabetes Obes Metab. 2020 Dec;22(12):2257-2266. PMID: 32700396
Lee G, Han JH, Maeng HJ, Lim S. Three-Month Daily Consumption of Sugar-Sweetened Beverages Affects the Liver, Adipose Tissue, and Glucose Metabolism. J Obes Metab Syndr. 2020 Mar 30;29(1):26-38. PMID: 32045514
Lim S, Shin SM, Nam GE, Jung CH, Koo BK. Proper Management of People with Obesity during the COVID-19 Pandemic. J Obes Metab Syndr. 2020 Jun 30;29(2):84-98. PMID: 32544885
Lim S, Oh B, Lee SH, Kim YH, Ha Y, Kang JH. Perceptions, Attitudes, Behaviors, and Barriers to Effective Obesity Care in South Korea: Results from the ACTION-IO Study. J Obes Metab Syndr. 2020 Jun 30;29(2):133-142. PMID: 32507770
Maeng HJ, Lee GY, Bae JH, Lim S. Effect of Fibroblast Growth Factor 21 on the Development of Atheromatous Plaque and Lipid Metabolic Profiles in an Atherosclerosis-Prone Mouse Model. Int J Mol Sci. 2020 Sep 17;21(18):6836. PMID: 32957703
Moon JH, Kang MK, Choi CE, Min J, Lee HY, Lim S. Validation of a wearable cuff-less wristwatch-type blood pressure monitoring device. Sci Rep. 2020 Nov 4;10(1):19015. PMID: 33149118
Moon JH, Lim S. Pharmacotherapy for patients with diabetes mellitus. J Korean Med Assoc. 2020 Dec 63(12):766-775
Lim S. Journal of Obesity & Metabolic Syndrome: A Platform for Acquiring and Disseminating the Most Recent Research Findings and Developing Research Concepts about Obesity. J Obes Metab Syndr. 2020 Dec 30;29(4):241-243. PMID: 33298625
[2019]
Lim S, Taskinen MR, Borén J. Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome. Obes Rev. 2019 Apr;20(4):599-611. PMID: 30589487
Lee DH, Chun EJ, Oh TJ, Kim KM, Moon JH, Choi SH, Park KS, Jang HC, Lim S. Effect of cilostazol, a phosphodiesterase-3 inhibitor, on coronary artery stenosis and plaque characteristics in patients with type 2 diabetes: ESCAPE study. Diabetes Obes Metab. 2019 Jun;21(6):1409-1418. PMID: 30761717
Lim S. Effects of sodium-glucose cotransporter inhibitors on cardiorenal and metabolic systems: Latest perspectives from the outcome trials. Diabetes Obes Metab. 2019 Apr;21 Suppl 2:5-8
Ahn CH, Lim S. Effects of Thiazolidinedione and New Antidiabetic Agents on Stroke. Journal of Stroke 2019 May;21(2):139-150. PMID: 31161759
Lim S, Min SH, Lee JH, Kim LK, Lee DH, Lee JE, Kim KM, Lee S, Park KC, Lee YJ. Components of Metabolic Syndrome in Korean Adults: A Hospital-Based Cohort at Seoul National University Bundang Hospital. J Obes Metab Syndr. 2019 Jun;28(2):118-128. PMID: 31294344
Lim S. Safety Issues with Sodium-Glucose Cotransporter 2 Inhibitors: Clinical Considerations. J Korean Diabetes 2019;20:127-135
Moon SJ, Chun EJ, Yoon YE, Park KS, Jang HC, Lim S. Long-Term Prognostic Value of Coronary Computed Tomography Angiography in an Asymptomatic Elderly Population. J Am Heart Assoc. 2019 Dec 3;8(23):e013523. PMID: 31752641
[2018]
Min SH, Oh TJ, Baek SI, Lee DH, Kim KM, Moon JH, Choi SH, Park KS, Jang HC, Lim S. Degree of Ketonemia and its Association with Insulin Resistance after Dapagliflozin Treatment in Type 2 Diabetes. Diabetes Metab. 2018 Feb;44(1):73-76. PMID: 29074329
Lim S. Eating a Balanced Diet: A Healthy Life through a Balanced Diet in the Age of Longevity. J Obes Metab Syndr. 2018 Mar 30;27(1):39-45. PMID: 31089539
Min SH, Kim SH, Jeong IK, Cho HC, Jeong JO, Lee JH, Kang HJ, Kim HS, Park KS, Lim S. Independent Association of Serum Aldosterone Level with Metabolic Syndrome and Insulin Resistance in Korean Adults. Korean Circ J. 2018 Mar;48(3):198-208. PMID: 29557106
Lim S, Eckel RH, Koh KK. Clinical implications of current cardiovascular outcome trials with sodium glucose cotransporter-2 (SGLT2) inhibitors. Atherosclerosis. 2018 Mar 8;272:33-40. PMID: 29547706
Lim S, Kim KM, Nauck MA. Glucagon-like Peptide-1 Receptor Agonists and Cardiovascular Events: Class Effects versus Individual Patterns. Trends Endocrinol Metab. 2018 Apr;29(4):238-248. PMID: 29463450
Lee SY, Ahn S, Kim YJ, Ji MJ, Kim KM, Choi SH, Jang HC, Lim S. Comparison between Dual-Energy X-ray Absorptiometry and Bioelectrical Impedance Analyses for Accuracy in Measuring Whole Body Muscle Mass and Appendicular Skeletal Muscle Mass. Nutrients. 2018 Jun 7;10(6). PMID: 29880741
Kim KM*, Lim S(cofirst)*, Oh TJ, Moon JH, Choi SH, Lim JY, Kim KW, PhD, Park KS, Jang HC. Longitudinal changes in muscle mass and strength, and bone mass in older adults: gender-specific associations between muscle and bone losses. J Gerontol A Biol Sci Med Sci. 2018 Jul 9;73(8):1062-1069. PMID: 29985994
Roh E, Kim KM, Park KS, Kim YJ, Chun EJ, Choi SH, Park KS, Jang HC, Lim S. Comparison of pancreatic volume and fat amount linked with glucose homeostasis between healthy Caucasians and Koreans. Diabetes Obes Metab. 2018 Nov;20(11):2642-2652. PMID: 29934972
[2017]
Lim S (first), Han KA, Yu JM, Chamnan P, Kim ES, Yoon KH, Kwon S, Moon MK, Lee KW, Kim DJ, Kim M, Wongtanate M, Kim EY, Kim SH, Lee MK; INICOM Study Group. Efficacy and safety of initial combination therapy with gemigliptin and metformin compared with monotherapy with either drug in patients with type 2 diabetes: a double-blind randomized controlled trial (INICOM study). Diabetes Obes Metab. 2017 Jan;19(1):87-97.
Han JH, Oh TJ, Lee G, Maeng HJ, Lee DH, Kim KM, Choi SH, Jang HC, Lee HS, Park KS, Kim YB, Lim S. The beneficial effects of empagliflozin, a sodium/glucose cotransporter 2 inhibitor, on atherosclerosis in ApoE–/– mice fed a Western diet. Diabetologia. 2017 Feb;60(2):364-376 (10.46)
Lim S (first), Lee GY, Park HS, Lee DH, Oh TJ, Kim KM, Kim YB, Jun HS, Jang HC, Park KS. Attenuation of carotid neointimal formation after direct delivery of a recombinant adenovirus expressing glucagon-like peptide-1 in diabetic rats. Cardiovasc Res. 2017 Feb;113(2):183-194. (13.081)
Lee DH, Chun EJ, Hur JH, Min SH, Lee JE, Oh TJ, Kim KM, Jang HC, Han SJ, Kang DK, Kim HJ, Lim S. Effect of sarpogrelate, a selective 5-HT2A receptor antagonist, on characteristics of coronary artery disease in patients with type 2 diabetes. Atherosclerosis. 2017 Feb;257:47-54.
Oh TJ, Lim S (cofirst author), Kim KM, Moon JH, Choi SH, Cho YM, Park KS, Jang H, Cho NH. One-hour postload plasma glucose concentration in people with normal glucose homeostasis predicts future diabetes mellitus: a 12-year community-based cohort study. Clin Endocrinol (Oxf). 2017 Apr;86(4):513-519.
Ahn CH, Min SH, Lee DH, Oh TJ, Kim KM, Moon JH, Choi SH, Park KS, Jang HC, Ha J, Sherman A, Lim S (corresponding). Hemoglobin Glycation Index Is Associated with Cardiovascular Diseases in People with Impaired Glucose Metabolism. J Clin Endocrinol Metab. 2017 Aug 1;102(8):2905-2913.
Min SH, Kong SH, Lee JE, Lee DH, Oh TJ, Kim KM, Park KS, Jang HC, Lim S. Association of angiotensin-II levels with albuminuria in subjects with normal glucose metabolism, prediabetes, and type 2 diabetes mellitus. J Diabetes Complications. 2017 Oct;31(10):1499-1505.
Kim YJ, Hwang SD, Oh TJ, Kim KM, Jang HC, Kimm H, Kim HC, Jee SH, Lim S. Association Between Obesity and Chronic Kidney Disease, Defined by Both Glomerular Filtration Rate and Albuminuria, in Korean Adults. Metab Syndr Relat Disord. 2017 Oct;15(8):416-422.
Toro-Ramos T, Lee DH, Kim Y, Michaelides A, Oh TJ, Kim KM, Jang HC, Lim S. Effectiveness of a Smartphone Application for the Management of Metabolic Syndrome Components Focusing on Weight Loss: A Preliminary Study. Metab Syndr Relat Disord. 2017 Nov;15(9):465-473
Lim S, Kim KM, Kim SG, Kim DM, Woo JT, Chung CH, Ko KS, Park JH, Park Y, Kim SJ, Jang HC, Choi DS. Effects of Lobeglitazone, a Novel Thiazolidinedione, on Bone Mineral Density in Patients with Type 2 Diabetes over 52 Weeks. Diabetes Metab J. 2017 Oct;41(5):377-385
Song YS, Oh TJ, Kim KM, Moon JH, Choi SH, Jang HC, Park KS, Lim S (corresponding). Application of the 2013 ACC/AHA Cholesterol Guideline to the Korean National Health and Nutrition Examination Surveys from 1998 to 2012. Diabetes Metab J. 2017 Feb;41(1):38-50.
Kim KM, Jin HJ, Lee SY, Maeng HJ, Lee GY, Oh TJ, Choi SH, Jang HC, Lim S (corresponding). Effects of Lobeglitazone, a New Thiazolidinedione, on Osteoblastogenesis and Bone Mineral Density in Mice. Endocrinol Metab (Seoul). 2017 Sep;32(3):389-395.
Lim S. Journal of Obesity & Metabolic Syndrome: A New International Journal Targeting the Pathophysiology and Treatment of Obesity and Metabolic Syndrome. J Obes Metab Syndr 2017 Sep;26:81-88.
[2016]
Jung KY, Kim KM, Ku EJ, Kim YJ, Lee DH, Choi SH, Jang HC, Shin CS, Park KS, Lim S (corresponding). Age- and Sex-specific Association of Circulating Osteocalcin with Dynamic Measures of Glucose Homeostasis. Osteoporos Int. 2016 Mar;27(3):1021-9.
Park KS, Lee DH, Lee JE, Jung KY, Kim YJ, Kim KM, Kwak SH, Choi SH, Jang HC, Lim S (corresponding). Comparison between two methods of bioelectrical impedance analyses for accuracy in measuring abdominal visceral fat area. J Diabetes Complications. 2016 Mar;30(2):343-9.
Lim S (first), Kang SM, Kim KM, Moon JH, Choi SH, Hwang H, Jung HS, Park KS, Ryu JO, Jang HC. Multifactorial Intervention in Diabetes Care Using Real-Time Monitoring and Tailored Feedback in Type 2 Diabetes. Acta Diabetologica 2016 Apr;53(2):189-98.
Kim KM, Jang HC, Lim S (corresponding). Differences among skeletal muscle mass indices derived from height-, weight-, and body mass index-adjusted models in assessing sarcopenia. Korean J Intern Med. 2016 Jul;31(4):643-50.
Kim LK, Yoon JW, Lee DH, Kim KM, Choi SH, Park KS, Jang HC, Kim MK, Park HE, Choi SY, Lim S (corresponding). Impact of metabolic syndrome on the progression of coronary calcium and of coronary artery disease assessed by repeated cardiac computed tomography scans. Cardiovasc Diabetol. 2016 Jun 28;15(1):92
Lee JE, Min SH, Lee DH, Oh TJ, Kim KM, Moon JH, Choi SH, Park KS, Jang HC, Lim S (corresponding). Comprehensive assessment of lipoprotein subfraction profiles according to glucose metabolism status, and association with insulin resistance in subjects with early-stage impaired glucose metabolism. Int J Cardiol. 2016 Dec 15;225:327-331.
[2015]
Hong ES, Khang AR, Roh E, Ku EJ, Kim YA, Kim KM, Moon JH, Choi SH, Park KS, Kim KW, Jang HC, Lim S (corresponding). Counterintuitive relationship between visceral fat and all-cause mortality in an elderly Asian population. Obesity 2015 Jan;23(1):220-7.
Moon JH*, Lim S* (cofirst), Han JW, Kim KM, Choi SH, Park KS, Kim KW, Jang HC. Carotid Intima-Media Thickness Is Associated With the Progression of Cognitive Impairment in Older Adults. Stroke. 2015 Apr;46(4):1024-30. (10.17)
Choi SH*, Lim S*(cofirst), Hong ES, Seo JA, Park CY, Noh JH, Mok JO, Lee KY, Park JS, Kim DJ, Lee CB, Kim SR, Jang HC. PROPIT: A PROspective comparative clinical study evaluating the efficacy and safety of PITavastatin in patients with metabolic syndrome. Clin Endocrinol (Oxf). 2015 May;82(5):670-7.
Ku EJ, Jung KY, Kim YJ, Kim KM, Moon JH, Choi SH, Cho YM, Park KS, Jang HC, Lim S (corresponding), Ahrén B. Four-year Durability of Initial Combination Therapy with Sitagliptin and Metformin in Patients with Type 2 Diabetes in Clinical Practice; COSMIC study. PLoS One 2015 Jun 12;10(6):e0129477
Kim KM, Lee KS, Lee GY, Jin H, Durrance ES, Park HS, Choi SH, Park KS, Kim YB, Jang HC, Lim S (corresponding). Anti-diabetic efficacy of KICG1338, a novel glycogen synthase kinase-3β inhibitor, and its molecular characterization in animal models of type 2 diabetes and insulin resistance. Mol Cell Endocrinol. 2015 Jul 5;409:1-10
Cho NH, Kim KM, Choi HS, Park KS, Jang HC, Kim SS, Sattar N, Lim S (corresponding). High Blood Pressure and Its Association with Incident Diabetes Mellitus over 10 Years in the Korean Genome and Epidemiology Study (KoGES), Diabetes Care 2015 Jul;38(7):1333-8.
Hong AR, Lee J, Ku EJ, Hwangbo Y, Kim KM, Moon JH, Choi SH, Jang HC, Lim S (corresponding). Comparison of vildagliptin as an add-on therapy and sulfonylurea dose-increasing therapy in patients with inadequately controlled type 2 diabetes using metformin and sulfonylurea (VISUAL study): A randomized trial. Diabetes Res Clin Pract 2015 Jul;109(1):141-8.
Moon JH*, Lim S*(cofirst), Han JW, Kim KM, Choi SH, Kim KW, Jang HC. Serum 25-hydroxyvitamin D level and the risk of mild cognitive impairment and dementia: the Korean Longitudinal Study on Health and Aging. Clinical Endocrinology 2015 Jul;83(1):36-42.
Lim S (first), Oh TJ, Koh KK. Mechanistic link between nonalcoholic fatty liver disease and cardiometabolic disorders. Int J Cardiol. 2015 Dec 15;201:408-14.
Lim S (first), Lee KS, Lee J, Park HS, Kim KM, Moon JH, Choi SH, Park KS, Kim YB, Jang HC. Effect of a new PPAR-gamma agonist, lobeglitazone, on neointimal formation after balloon injury in rats and the development of atherosclerosis. Atherosclerosis 2015 Sep 4;243(1):107-119
Hong AR, Lim S (corresponding). Clinical Characteristics of Metabolic Syndrome in Korea and Its Comparison with Other Asian Countries. J Diabetes Investig. 2015 Sep 6;5:508-515
Kim KM, Park KS, Lee HJ, Lee YH, Bae JS, Lee YJ, Choi SH, Jang HC, Lim S (corresponding). Efficacy of a New Medical Information system, Ubiquitous Healthcare Service with Voice Inception Technique in Elderly Diabetic Patients. Sci Rep. 2015 Dec 11;5:18214.
Cho NH, Oh TJ, Kim KM, Choi SH, Lee JH, Park KS, Jang HC, Kim JY, Lee HK, Lim (corresponding)S. Neck Circumference and Incidence of Diabetes Mellitus over 10 Years in the Korean Genome and Epidemiology Study (KoGES). Sci Rep. 2015Dec 18;5:18565
Lee DH, Park KS, Ahn S, Ku EJ, Jung KY, Kim YJ, Kim KM, Moon JH, Choi SH, Park KS, Jang HC, Lim S (corresponding). Comparison of Abdominal Visceral Adipose Tissue Area Measured by Computed Tomography with That Estimated by Bioelectrical Impedance Analysis method in Korean subjects. Nutrients. 2015 Dec 16;7(12):10513-24. (SCI IF= 3.550)
Kim KM, Lim S*(cofirst), Choi KM, Kim JH, Yu SH, Kim TN, Song W, Lim JY, Won CW, Yoo HJ, Jang HC. Sarcopenia Study Group of Korean Geriatrics Society. Sarcopenia in Korea. J Korean Geriatr Soc 2015;19(1):1-8
[2014]
Lim S, Sakuma I, Quon MJ, Koh KK. Differential Metabolic Actions of Specific Statins: Clinical and Therapeutic Considerations. Antioxid Redox Sign. 2014 Mar 10;20(8):1286-99. (SCI IF= 7.468)
Lim S, Quon JM, Koh KK. Modulation of Circulating Adiponectin Levels as a Potential Therapeutic Strategy. Atherosclerosis. 2014 Apr;233(2):721-728.
Jin CJ, Yu SH, Wang XM, Woo SJ, Park HJ, Lee HC, Choi SH, Kim KM, Kim JH, Park KS, Jang HC, Lim S (corresponding). The effect of lithospermic Acid, an antioxidant, on development of diabetic retinopathy in spontaneously obese diabetic rats. PLoS One. 2014 Jun 6;9(6):e98232.
Hong ES, Kim EK, Kang SM, Khang AR, Choi SH, Park KS, Jang HC, Lim S (corresponding). Effect of carnitine-orotate complex on glucose metabolism and fatty liver: a double-blind, placebo-controlled study. J Gastroen Hepatol. 2014 Jul;29(7):1449-57
Lim S, Oh PC, Sakuma I, Koh KK. How to balance cardiorenometabolic benefits and risks of statins. Atherosclerosis. 2014 Aug;235(2):644-648.
Lim S, Choi SH, Kim KM, Choi SI, Chun EJ, Kim MJ, Park KS, Jang HC, Sattar N. The Association of Rate of Weight Gain During Early Adulthood on the Prevalence of Subclinical Coronary Artery Disease in Recently Diagnosed Type 2 Diabetes: the MAXWEL-CAD Study. Diabetes Care. 2014 Sep;37(9):2491-9.
Lim S, Meigs JB. Links Between Ectopic Fat and Vascular Disease in Humans. Arterioscler Thromb Vasc Biol. 2014 Sep;34(9):1820-6. (10.514)
Lim S, Bae JH, Chun EJ, Kim H, Kim SY, Kim KM, Choi SH, Park KS, Florez JC, Jang HC. Differences in pancreatic volume, fat content, and fat density measured by multidetector-row computed tomography according to the duration of diabetes. Acta Diabetol. 2014 Oct;51(5):739-48
Kim JH, Lim S (cofirst), Choi SH, Kim KM, Yoon JW, Kim KW, Lim JY, Park KS, Jang HC. Sarcopenia: An Independent Predictor of Mortality in Community-Dwelling Older Men. J Gerontol A Biol Sci Med Sci. 2014 Oct;69(10):1244-52.
Lim S, Stember KG, He W, Bianca PC, Yelibi C, Marquis A, Stürmer Til, Buse JB, Meigs JB. Electronic medical record cancer incidence over six years comparing new users of glargine with new users of NPH insulin. PLoS One. 2014 Oct 20;9(10):e109433.
Lim S, Barter P. Antioxidant Effects of Statins in the Management of Cardiometabolic Disorders. J Atheroscler Thromb. 2014 Oct 24;21(10):997-1010.
Kim YA, Ku EJ, Khang AR, Hong ES, Kim KM, Moon JH, Choi SH, Park KS, Jang HC, Lim S (corresponding). Role of Various Indices Derived from an Oral Glucose Tolerance Test in the Prediction of Conversion from Prediabetes to Type 2 Diabetes. Diabetes Res Clin Pract 2014 Nov;106(2):351-9.
Lim S, Eckel RH. Pharmacological treatment and therapeutic perspectives of metabolic syndrome. Rev Endocr Metab Disord. 2014 Dec;15(4):329-41.
Kim KM, Lim S (cofirst author), Choi SH, Kim JH, Shin CS, Park KS, Jang HC. Cardiometabolic Implication of Sarcopenia: The Korea National Health and Nutrition Examination Study (KNHANES) 2008-2010. Int J Cardiol Metabolic & Endocrine 2014 Sep;4:63-69.
Jung KY, Kim KM, Lim S (corresponding). Therapeutic Approaches for Preserving or Restoring Pancreatic β-Cell Function and Mass. Diabetes Metab J. 2014 Dec;38(6):426-36.
Lim S (first and corresponding). Ectopic Fat Assessment Focusing on Cardiometabolic and Renal Risk. Endocrinol Metab. 2014 Mar;29(1):1-4.
[2013]
Lim S (first), Jang HC, Park KS, Cho SI, Lee MG, Joung H, Mozumdar A, Liguori G. Changes in Metabolic Syndrome in American and Korean Youth, 1997-2008. Pediatrics. 2013 Jan;131(1):e214-22. (9.703)
Lim S (first), Kim MJ, Choi SH, Shin CS, Park KS, Jang HC, Billings LK, Meigs JB. Association of Vitamin D Deficiency with Incidence of Type 2 Diabetes in High Risk Asian Subjects. Am J Clin Nutr. 2013 Mar;97(3):524-30.
Lim S (first), Park YM, Sakuma I, Koh KK. How to control residual cardiovascular risk despite statin treatment: Focusing on HDL–cholesterol. Int J Cardiol. 2013 Jun 5;166(1):8-14
Lim S (first), Hong J, Liu CT, Hivert MF, White CC, Murabito JM, O`Donnell CJ, Dupuis J, Florez JC, Meigs JB. Common variants in and near IRS1 and subclinical cardiovascular disease in the Framingham Heart Study. Atherosclerosis. 2013 Jul;229(1): 149-54.
Lim S (first), Sakuma I, Quon MJ, Koh KK. Potentially important considerations in choosing specific statin treatments to reduce overall morbidity and mortality. Int J Cardiol. 2013 Sep 1;167(5):1696-702
Lim S (first), Meigs JB. Ectopic fat and Cardiometabolic and Vascular risk. Int J Cardiol. 2013 Nov 5;169(3):166-76
Lim S (first), Kim KM, Kim MJ, Woo SJ, Choi SH, Park KS, Jang HC, Meigs JB, Wexler DJ. The Association of Maximum Body Weight on the Development of Type 2 Diabetes and Microvascular Complications: MAXWEL study. PLOS One. 2013 Dec 4;8(12):e80525.
Yoon JW, Cho BJ, Park HS, Kang SM, Choi SH, Jang HC, Shin H, Lee MJ, Kim YB, Park KS, Lim S (corresponding). Differential effects of trimetazidine on vascular smooth muscle cell and endothelial cell in response to carotid artery balloon injury in diabetic rats. Int J Cardiol. 2013 Jul 15;167(1):126-33.
Choi SH, Hong ES, Lim S (corresponding). Clinical implications of adipocytokines and newly emerging metabolic factors with relation to insulin resistance and cardiovascular health. Front Endocrinol (Lausanne). 2013 Aug 21;4:97.
Roh E, Ko SH, Kwon HS, Kim NH, Kim JH, Kim CS, Song KH, Won JC, Kim DJ, Choi SH, Lim S (corresponding), Cha BY. Prevalence and management of dyslipidemia in Korea; Korea National Health and Nutrition Examination Survey during 1998–2010. Diabetes Metab J. 2013 Dec;37(6):433-49.
[2012]
Lim S, Choi SH, Koo BK, Kang SM, Yoon JW, Jang HC, Choi SM, Lee MG, Lee W, Shin H, Kim YB, Lee HK, Park KS. Effects of Aerobic Exercise Training on C1q Tumor Necrosis Factor α-Related Protein Isoform 5 (Myonectin): Association with Insulin Resistance and Mitochondrial DNA Density in Women. J Clin Endocrinol Metab. 2012 Jan;97(1):E88-93.
Lim S, Shin H, Kim MJ, Ahn HY, Kang SM, Yoon JW, Choi SH, Kim KW, Song JH, Choi SI, Chun EJ, Shin CS, Park KS, Jang HC. Vitamin D inadequacy is associated with significant coronary artery stenosis in a community-based elderly cohort: the Korean longitudinal study on health and aging. J Clin Endocrinol Metab. 2012 Jan;97(1):169-78.
Lim S, Choi HJ, Shin H, Khang AR, Kang SM, Yoon JW, Choi SH, Jeong IK, Cho SI, Park KS, Jang HC. Subclinical atherosclerosis in a community-based elderly cohort: The Korean Longitudinal Study on Health and Aging. Int J Cardiol. 2012 Feb 23;155(1):126-33.
Lim S, Kim JH, Yoon JW, Kang SM, Choi SH, Park YJ, Kim KW, Cho NH, Shin H, Park KS, Jang HC. Optimal cut points of waist circumference (WC) and visceral fat area (VFA) predicting for metabolic syndrome (MetS) in elderly population in the Korean Longitudinal Study on Health and Aging (KLoSHA). Arch Gerontol Geriatr. 2012 Mar;54(2):e29-34.
Lim S, Choi SH, Shin H, Cho BJ, Park HS, Ahn BY, Kang SM, Yoon JW, Jang HC, Kim YB, Park KS. Effect of a dipeptidyl peptidase-IV inhibitor, des-fluoro-sitagliptin, on neointimal formation after balloon injury in rats. PLOS One. 2012 Apr;7(4):e35007.
Yoon JW, Kang SM, Vassy JL, Shin H, Lee YH, Ahn HY, Choi SH, Park KS, Jang HC, Lim S. Efficacy and safety of ginsam, a vinegar extract from Panax ginseng, in type 2 diabetic patients: Results of a double-blind, placebo-controlled study. Journal of Diabetes Investigation. 2012 Jun;3:309-317
Lim S, An JH, Shin H, Khang AR, Lee Y, Ahn HY, Yoon JW, Kang SM, Choi SH, Cho YM, Park KS, Jang HC. Factors predicting therapeutic efficacy of combination treatment with sitagliptin and metformin in type 2 diabetic patients: the COSMETIC Study. Clin Endocrinol 2012 Aug;77(2):215-23
Hong ES, Khang AR, Yoon JW, Kang SM, Choi SH, Park KS, Jang HC, Shin H, Walford GA, Lim S. Comparison between sitagliptin as add-on therapy to insulin and insulin dose-increase therapy in uncontrolled Korean type 2 diabetes: CSI study. Diabetes Obes Metab. 2012 Sep;14(9):795-802
Lee Y, Shin H, Vassy JL, Kim JT, Cho SI, Kang SM, Choi SH, Kim KW, Park KS, Jang HC, Lim S. Comparison of regional body composition and its relation with cardiometabolic risk between BMI-matched young and old subjects. Atherosclerosis. 2012 Sep;224(1):258-265
Lim S, Rutter MK, Unfavorable Effects of Intensive Glucose Lowering on Mortality: Lessons from the 5-Year Follow-up of the ACCORD Trial. Current Cardiovascular Risk Reports 2012 Feb, 6(1):1-3
Lim S, Hivert MF. Update on the Role of Adipokines in Atherosclerosis and Cardiovascular Diseases. Current Cardiovascular Risk Reports 2012 Feb, 6(1):53-61
[2011]
Lim S, Kang SM, Shin H, Lee HJ, Won Yoon J, Yu SH, Kim SY, Yoo SY, Jung HS, Park KS, Ryu JO, Jang HC. Improved glycemic control without hypoglycemia in elderly diabetic patients using the ubiquitous healthcare service, a new medical information system. Diabetes Care. 2011 Feb;34(2):308-13.
Kim TH, Yu SH, Choi SH, Yoon JW, Kang SM, Chun EJ, Choi SI, Shin H, Lee HK, Park KS, Jang HC, Lim S (corresponding author). Pericardial Fat Amount Is an Independent Risk Factor of Coronary Artery Stenosis Assessed by Multidetector-Row Computed Tomography: The Korean Atherosclerosis Study 2. Obesity (Silver Spring) 2011 May;19(5):1028-34.
Lim S, Despres JP, Koh KK. Prevention of atherosclerosis in overweight/obese patients. - In need of novel multi-targeted approaches-. Circ J. 2011 May;75:1019-1027.
Lim S, Moon MK, Shin H, Kim TH, Cho BJ, Kim M, Park HS, Choi SH, Ko SH, Chung MH, Lee IK, Jang HC, Kim YB, Park KS. Effect of S-adenosylmethionine on neointimal formation after balloon injury in obese diabetic rats. Cardiovasc Res. 2011 May 1;90(2):383-93.
Lim S, Yoon JW, Kang SM, Choi SH, Cho BJ, Kim M, Park HS, Cho HJ, Shin H, Kim YB, Kim HS, Jang HC, Park KS. EGb761, a Ginkgo Biloba Extract, Is Effective Against Atherosclerosis In Vitro, and in a Rat Model of Type 2 Diabetes. PLoS One. 2011 Jun;6(6):e20301.
Lim S, Shin H, Song JH, Kwak SH, Kang SM, Won YJ, Choi SH, Cho SI, Park KS, Lee HK, Jang HC, Koh KK. Increasing prevalence of metabolic syndrome in Korea: the Korean national health and nutrition examination survey for 1998-2007. Diabetes Care. 2011 Jun;34:1323-1328.
Sung KC*, Lim S*, Rosenson RS. Hyperinsulinemia and homeostasis model assessment of insulin resistance as predictors of hypertension: a 5-year follow-up study of Korean sample. Am J Hypertens. 2011 Sep;24(9):1041-5. (*cofirst author)
Lim S, Kwon SY, Yoon JW, Kim SY, Choi SH, Park YJ, Yoon HI, Chang YS, Lee JH, Lee CT, Kim KW, Park KS, Jang HC. Association Between Body Composition and Pulmonary Function in Elderly People: The Korean Longitudinal Study on Health and Aging. Obesity (Silver Spring). 2011 Mar;19:631-8.
Kang SM, Yoon JW, Ahn HY, Kim SY, Lee KH, Shin H, Choi SH, Park KS, Jang HC, Lim S. Android fat depot is more closely associated with metabolic syndrome than abdominal visceral fat in elderly people. PLoS One. 2011 Nov;6(11):e27694.
Lim S, Shin H, Lee Y, Yoon JW, Kang SM, Choi SH, Park KS, Jang HC, Choi SI, Chun EJ. Effect of metabolic syndrome on coronary artery stenosis and plaque characteristics as assessed with 64-detector row cardiac CT. Radiology. 2011 Nov;261(2):437-45.
Lim S, Kim SY, Kim JI, Kwon MK, Min SJ, Yoo SY, Kang SM, Kim HI, Jung HS, Park KS, Ryu JO, Shin H, Jang HC. A Survey on Ubiquitous Healthcare Service Demand among Diabetic Patients. Diabetes Metab J. 2011 Feb;35(1):50-7.
[2010]
Lim S, Cho YM, Park KS, Lee HK. Persistent organic pollutants, mitochondrial dysfunction, and metabolic syndrome. Ann N Y Acad Sci. 2010 Jul;1201:166-76.
Lim S, Kim JH, Yoon JW, Kang SM, Choi SH, Park YJ, Kim KW, Lim JY, Park KS, Jang HC. Sarcopenic Obesity: Prevalence and Association with Metabolic Syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA). Diabetes Care 2010 Jul;33:1652-4.
Lim S, Yoon JW, Choi SH, Park YJ, Lee JJ, Park JH, Lee SB, Kim KW, Lim JY, Kim YB, Park KS, Lee HK, Cho SI, Jang HC. Combined Impact of Adiponectin and Retinol-binding protein 4 on Metabolic Syndrome in Elderly People. Obesity 2010 Apr;18(4):826-32.
Kim JH, Bo YH, Hong ES, Ohn JH, Kim CH, Kim HW, Ahn HY, Yoon JW, Kang SM, Park YJ, Jang HC, Lim S (corresponding author). Investigation of Sarcopenia and Its Association with Cardiometabolic Risk Factors in Elderly Subjects. J Korean Geriatr Soc 14(3):121-130, 2010
Lim S, Evaluation of Body Composition by Various Methods. The Korean Journal of Obesity 2010 19:155-158
[2009]
Lim S, Yoon JW, Choi SH, Cho BJ, Kim JT, Chang HS, Park HS, Park KS, Lee HK, Kim YB, Jang HC. Effect of ginsam, a vinegar extract from Panax ginseng, on body weight and glucose homeostasis in an obese insulin-resistant rat model. Metabolism 58: 8-15, 2009
Lim S, Son KR, Song IC, Park HS, Jin CJ, Jang HC, Park KS, Kim YB, Lee HK. Fat in liver/muscle correlates more strongly with insulin sensitivity in rats than abdominal fat. Obesity 17: 188-195, 2009
Lim S, Choi SH, Choi EK, Yoon YE, Ku YH, Chun EJ, Choi SI, Jang HC, Chang HJ. Comprehensive Evaluation of Coronary Arteries by Multidetector-row Cardiac Computed Tomography according to the Glucose Level of Asymptomatic Individuals. Atherosclerosis Jul;205(1):156-62, 2009.
Lim S, Ahn SY, Song IC, Chung MH, Jang HC, Park KS, Lee KU, Pak YK, Lee HK. Chronic Exposure to the Herbicide, Atrazine, Causes Mitochondrial Dysfunction and Insulin Resistance. PLOS one 4(4):e5186, 2009
Lim S, Ahn BY, Chung SS, Park HS, Cho BJ, Kim M, Choi SH, Lee IK, Lee SW, Choi SJ, Chung CH, Cho YM, Lee HK, Park KS. Effect of a peroxisome proliferator activated receptor gamma sumoylation mutant on neointimal formation after balloon injury in rats. Atherosclerosis Oct;206(2):411-7, 2009
[2008]
Lim S, Jang HC, Park KS, Lee HK, Chung HR, Joung HJ, Cho SI. Changes in Metabolic Syndrome of Korean Children and Adolescents in the Period 1998 to 2001. J Endocrinol Invest.31:327-333, 2008
Lim S, Koo BK, Lee EJ, Park JH, Kim MH, Shin KH, Ha YC, Cho NH, Shin CS. Incidence of hip fractures in Korea. J Bone Miner Metab 26:400-405, 2008
Koo BK, An JH, Jeon KH, Choi SH, Cho YM, Jang HC, Chung JH, Lee CH, Lim S*. Two cases of ectopic adrenocorticotropic hormone syndrome with olfactory neuroblastoma and literature review. Endocrine Journal 55:469-475, 2008.
Lim S, Koo BK, Cho SW, Kihara S, Funahashi T, Cho YM, Kim SY, Lee HK, Shimomura I, Park KS. Association of adiponectin and resistin with cardiovascular events in Korean patients with type 2 diabetes: the Korean Atherosclerosis Study (KAS). Atherosclerosis 196:398-404, 2008.
Oh JY, Lim S*(Co-first author), Kim DJ, Kim NH, Kim DJ, Moon SD, Jang HC, Cho YM, Song KH, Ahn CW, Sung YA, Park JY, Shin C, Lee HK, Park KS. A Report on the Diagnosis of Intermediate Hyperglycemia in Korea: A Pooled Analysis of Four Community-based Cohort Studies. Diabetes Res Clin Pract 80:463-468, 2008.
Lim S, Choi SH, Jeong IK, Kim JH, Moon MK, Park KS, Lee HK, Kim YB, Jang HC. Insulin-sensitizing Effects of Exercise on Adiponectin and Retinol Binding Protein-4 Concentrations in Young and Middle-aged Women. J Clin Endocrinol Metab 93:2263-2268, 2008.
Lim S C, Jang HC. Clinical Implication of Adiponectin. Korean Diabetes J 32:85~97, 2008
Lim S, Relationship Between Serum Bilirubin Levels and Coronary Atherosclerosis in Patients with Type 2 Diabetes (letter) Korean Diabetes J 32:462~463, 2008
[2007]
Lim S, Choi SH, Park YJ, Park KS, Lee HK, Jang HC, Cho NH, Boyd Metzger. Visceral Fatness and Insulin Sensitivity in Women with a Previous History of Gestational Diabetes Mellitus. Diabetes Care 30:348-353, 2007
Oh JY, Lim S*(Co-first author), Kim DJ, Kim NH, Kim DJ, Moon SD, Jang HC, Cho YM, Song KH, Park KS. A Report on the Diagnosis of Diabetes Mellitus in Korea: A Pooled Analysis of Four Community-based Cohort Studies. Diabetic Medicine 24, 217-220, 2007
Cho NH, Jang HC, Choi SH, Kim HR, Lee HK, Chan J, Lim S (corresponding author). Abnormal Liver Function Test Predicts Type 2 Diabetes: A Community-based Prospective Study. Diabetes Care 2007 30: 2566-2568
Lim S, Kang SM, Shin H, Lee HJ, Won Yoon J, Yu SH, Kim SY, Yoo SY, Jung HS, Park KS, Ryu JO, Jang HC. Improved glycemic control without hypoglycemia in elderly diabetic patients using the ubiquitous healthcare service, a new medical information system. Diabetes Care. 2011 Feb;34(2):308-13.
Kim TH, Yu SH, Choi SH, Yoon JW, Kang SM, Chun EJ, Choi SI, Shin H, Lee HK, Park KS, Jang HC, Lim S (corresponding author). Pericardial Fat Amount Is an Independent Risk Factor of Coronary Artery Stenosis Assessed by Multidetector-Row Computed Tomography: The Korean Atherosclerosis Study 2. Obesity (Silver Spring) 2011 May;19(5):1028-34.
Lim S, Despres JP, Koh KK. Prevention of atherosclerosis in overweight/obese patients. - In need of novel multi-targeted approaches-. Circ J. 2011 May;75:1019-1027.
Lim S, Moon MK, Shin H, Kim TH, Cho BJ, Kim M, Park HS, Choi SH, Ko SH, Chung MH, Lee IK, Jang HC, Kim YB, Park KS. Effect of S-adenosylmethionine on neointimal formation after balloon injury in obese diabetic rats. Cardiovasc Res. 2011 May 1;90(2):383-93.
Lim S, Yoon JW, Kang SM, Choi SH, Cho BJ, Kim M, Park HS, Cho HJ, Shin H, Kim YB, Kim HS, Jang HC, Park KS. EGb761, a Ginkgo Biloba Extract, Is Effective Against Atherosclerosis In Vitro, and in a Rat Model of Type 2 Diabetes. PLoS One. 2011 Jun;6(6):e20301.
Lim S, Shin H, Song JH, Kwak SH, Kang SM, Won YJ, Choi SH, Cho SI, Park KS, Lee HK, Jang HC, Koh KK. Increasing prevalence of metabolic syndrome in Korea: the Korean national health and nutrition examination survey for 1998-2007. Diabetes Care. 2011 Jun;34:1323-1328.
Sung KC*, Lim S*, Rosenson RS. Hyperinsulinemia and homeostasis model assessment of insulin resistance as predictors of hypertension: a 5-year follow-up study of Korean sample. Am J Hypertens. 2011 Sep;24(9):1041-5. (*cofirst author)
Lim S, Kwon SY, Yoon JW, Kim SY, Choi SH, Park YJ, Yoon HI, Chang YS, Lee JH, Lee CT, Kim KW, Park KS, Jang HC. Association Between Body Composition and Pulmonary Function in Elderly People: The Korean Longitudinal Study on Health and Aging. Obesity (Silver Spring). 2011 Mar;19:631-8.
Kang SM, Yoon JW, Ahn HY, Kim SY, Lee KH, Shin H, Choi SH, Park KS, Jang HC, Lim S. Android fat depot is more closely associated with metabolic syndrome than abdominal visceral fat in elderly people. PLoS One. 2011 Nov;6(11):e27694.
Lim S, Shin H, Lee Y, Yoon JW, Kang SM, Choi SH, Park KS, Jang HC, Choi SI, Chun EJ. Effect of metabolic syndrome on coronary artery stenosis and plaque characteristics as assessed with 64-detector row cardiac CT. Radiology. 2011 Nov;261(2):437-45.
Lim S, Kim SY, Kim JI, Kwon MK, Min SJ, Yoo SY, Kang SM, Kim HI, Jung HS, Park KS, Ryu JO, Shin H, Jang HC. A Survey on Ubiquitous Healthcare Service Demand among Diabetic Patients. Diabetes Metab J. 2011 Feb;35(1):50-7.
[2006]
Lim S, Jin CJ, Kim M, Chung SS, Park HS, Lee IK, Lee CT, Cho YM, Lee HK, Park KS. PPARgamma gene transfer sustains apoptosis, inhibits vascular smooth muscle cell proliferation, and reduces neointima formation after balloon injury in rats. Arterioscler Thromb Vasc Bio. 26: 808-813, 2006
Lim S, Jang HC, Lee HK, Kimm KC, Park C, Cho NH. The relationship between body fat and C-reactive protein in middle-aged Korean population. Atherosclerosis 2006 184: 171-177
Lim S, Jang HC, Lee HK, Kimm KC, Park C and Cho NH. A rural-urban comparison of the characteristics of metabolic syndrome by gender in Korea: The Korean Health and Genome Study (KHGS). J Endocrinol Invest 29: 313-319, 2006
Lim S, Postprandial hyperglycemia and complication. Korean Clinical Diabetes 7:207-211, 2006.
[2005]
Lim S, Park KS, Lee HK, Cho SI. Changes in the Characteristics of Metabolic Syndrome in Korea over the Period 1998-2001 as Determined by Korean National Health and Nutrition Examination Surveys. Diabetes Care 28:1810-1812, 2005
Lim S, Lee HK, Kimm KC, Park C, Shin C, Cho NH. C-reactive protein level as an independent risk factor of metabolic syndrome in the Korean population. Diabetes Res Clin Pract 70: 126-133, 2005
Lim S, Lee EJ, Koo BK, Cho SI, Park KS, Jang HC, Kim SY, Lee HK. Increasing Trends of Metabolic Syndrome in Korea. Korean Diabetes J 29:432-439, 2005
[2004]
Lim S, Joung HJ, Shin CS, Lee HK, Kim HK, Shin EK, Kim HY, Lim MK, Cho SI. Body Composition Changes with Age have Gender Specific Impacts on Bone Mineral Density. Bone 35:792-798, 2004
Lim S, Choi HS, Shin HJ, Ahn JH, Baik JJ, Choi YH, Lee JK. Three cases of severe acute respiratory syndrome imported into South Korea. The Korean Journal of Medicine. 67(6):655~662, 2004
Lim S, Park KS, Metabolic syndrome and Peroxisome proliferator-activated receptor. J Kor Soc Endocrinol 19:256-266, 2004.
Lim S, Park SM, Choi HS, Kim DK, Kim HB, Yang BG, Lee JK. Transverse myelitis after measles and rubella vaccination. Journal of Pediatrics and Child Health 40:583-584, 2004
[2000-2003]
Lim S, Kim SK, Park KS, Kim SY, Cho BY, Yim MJ, Lee HK, Effect of exercise on the mitochondrial DNA content of peripheral blood in healthy women, Eur J Appl Physiol 82: 407-412, 2000
Lim S, Kim MS, Park KS, Lee JH, An GH, Yim MJ, Song JH, Park YK, Lee HK, Correlation of plasma homocysteine and mitochondrial DNA content in peripheral blood in healthy women, Atherosclerosis 158:399-405,2001
Lim S, Park KS, Kim MS, Cho BY, Lee HK, Relationship between various surrogate indices of insulin resistance and mitochondrial DNA content in the peripheral blood of 18 healthy volunteers, Mitochondrion 1:71-77, 2001
Lim S, Kwon KH, Kim EJ, Lim DS, Lim HJ, Cho SI, Lee YY, Park KS, Lee HK. Characteristics of Metabolic Syndrome and its Relationship with the Factors Related to Obesity in Rural Area. J Kor Soc Lipid and Athero 12:370-371, 2002
Lim S, Shin CS, Kim KS, Kim SY, Bang EJ, Shin EK, Choi HR, Chung MH, Cho SI. Determinants of Limb-Bone Mineral Density in healthy Men and Women Aged over 50 in Rural Area. J Kor Soc Endocrinol 18:193-205, 2003.
번호 | 매체명 | 제목 | 발간일 |
---|---|---|---|
813 | 데일리벳 | 혈당강하제 SGLT-2 억제제, 국내 당뇨병 개에 적용하자 혈당관리 도움 | 2024-07-29 |
812 | 청년의사 | 당뇨약제 병용 급여 반기지만 아직 웃지 못하는 진료현장 | 2024-06-24 |
811 | 힛뉴스 | "비만약, 체중 감소만 능사 아냐… 근손실·심혈관 개선 동반 중요" | 2024-04-05 |
810 | 스포츠경향 | ‘생로병사의 비밀’ 900회 특집, 의사가 전하는 ‘생로병사의 비밀’은? | 2024-03-06 |
809 | 코메디닷컴 | 노보 노디스크, ‘세계 비만의 날’ 인식 개선 토크 콘서트 열어 | 2024-03-04 |
808 | 헬스조선 | 밥 먹었는데 손발 덜덜… “극심한 허기가 저혈당 탓 아니래요!”[밀당365] | 2024-02-07 |
807 | 메디칼트리뷴 | "당뇨환자 심부전억제 · 신장보호에 SGLT2억제제" | 2024-01-22 |
806 | 뉴스1 | "오메가3 섭취시 심방세동 위험 증가" 주의…광동 등 93개 품목 적용 | 2024-01-03 |
805 | 메디칼업저버 | Implication of Ectopic Fat in People with Relatively Low BMI | 2023-11-17 |
804 | 청년의사 | "오메가3 섭취 통해 사회적 비용 年3천억 절감"…근거는? | 2023-10-16 |